Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000696381 | SCV000824941 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid with valine at codon 485 of the AIRE protein (p.Glu485Val). The glutamic acid residue is moderately conserved and there is a moderate physicochemical difference between glutamic acid and valine. This variant is present in population databases (rs779510704, ExAC 0.006%). This variant has not been reported in the literature in individuals affected with AIRE-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV000696381 | SCV002076135 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2019-10-28 | no assertion criteria provided | clinical testing |